Grant Opportunity: Clinical Pathways in Breast Cancer Program Grant

17 May 2017
NCCN

NCCN Pfizer Inc. Clinical Pathways in Breast Cancer Program Grant Opportunity – Submit Letter of Intent (LOI) by 26 June 2017

Pfizer Inc. and the National Comprehensive Cancer Network® ("NCCN") are collaborating to offer a new grant opportunity seeking proposals that use clinical care pathways to address a quality improvement initiative along the continuum of care for breast cancer patients.

The National Comprehensive Cancer Network® ("NCCN") is collaborating with Pfizer’s Independent Grants for Learning & Change ("IGLC") team to offer a new grant opportunity seeking proposals that use clinical pathways to address a quality improvement ("QI") initiative along the continuum of care for breast cancer patients.

The Request for Proposals ("RFP") clearly outlines the scope and process that will be followed for the submission of Letters of Intent ("LOI"s). 

The intent of the RFP is to encourage organizations to submit LOIs describing concepts and ideas for developing, implementing and evaluating guideline based clinical pathways in breast cancer.

NCCN views this collaboration with Pfizer’s IGLC team as clear recognition of the advantages offered to industry and organizations treating cancer patients through the NCCN Oncology Research Program. 

In the context of this Request for Proposals ("RFP"), a clinical pathway is defined as an evidence-based and systems-based standardization of a clinical process in order to support decision-making and improve the quality of breast cancer patient care.

Request for proposals: https://www.nccn.org/clinical_trials/investigators/rfp/pdf/NCCN_Pfizer.pdf

LOIs are due by 11:59pm EDT, 26 June 2017.Letters of intent due 26 June 2017.

Further information:

If you have any questions regarding this RFP, please direct them in writing to the Pfizer Grant Officer for this clinical area; Jacqueline Waldrop at Jacqueline.waldrop@pfizer.com with the subject line, “2017 Clinical Pathways in Breast Cancer.

NCCN and Pfizer Inc. Grant Opportunity - Submit by 26 June 2017

NCCN ORP website